Key result
ECMO successfully supports a pregnant woman with fulminant myocarditis to cardiac recovery and safe discharge.
Why the study?
There are no prior reports of pregnant women with fulminant myocarditis treated with Extracorporeal Membrane Oxygenation (ECMO).
Does ECMO improve survival in a pregnant woman with fulminant myocarditis?
Case Report (n=1)
No
Does ECMO improve survival in a pregnant woman with fulminant myocarditis?
ECMO can be a successful life-saving treatment for pregnant women presenting with fulminant myocarditis.
Answers are grounded in this paper and cite their sources.
Supports ECMO feasibility in pregnant fulminant myocarditis; leaves open survival benefit confirmation beyond this case.
INTRODUCTION: There are no reports regarding a pregnant woman with fulminant myocarditis underwent Extracorporeal Membrane Oxygenation (ECMO). Hence, we report a case of successful ECMO treatment of fulminant myocarditis puerpera. CASE PRESENTATION: A 32-year-old puerpera was admitted to our hospital with menopause for 7 months, fetal movement for 3 months and fever for 1 day. After admission, the patient's body temperature increased repeatedly, heart rate increased, and the whole process C-reactive protein increased rapidly. Considered a diagnosis of fulminant myocarditis. After antiviral and cardioprotective treatment, the heart function progressively worsened. Pregnancy was terminated, the newborn was intubated in the neonatal room for rescue after surgery, and ECMO treatment was given after the puerpera was transferred to the intensive care unit. Finally, the patient and the baby have been safely discharged from hospital. DISCUSSION: ECMO can provide cardiac and respiratory support. Fulminant myocarditis is common in children, adolescents and particularly pregnant women who had the highest mortality rate. In the pregnant woman with fulminant myocarditis described in this report, antiviral treatment only transiently improved heart function and then heart function progressively worsened. After receiving ECMO therapy, the patient's cardiac function has improved markedly. The patient was then successfully weaned from ECMO. To our knowledge, this is the first report of pregnant woman in whom ECMO was part of the treatment for fulminant myocarditis. CONCLUSION: We report a case of successful ECMO treatment of fulminant myocarditis puerpera. ECMO can be the treatment of choice for pregnant women with fulminant myocarditis.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2021) conducted a case report in Fulminant myocarditis (n=1). Extracorporeal Membrane Oxygenation (ECMO) was evaluated on Clinical recovery and survival. Extracorporeal membrane oxygenation successfully supported a 32-year-old pregnant woman with fulminant myocarditis, leading to marked improvement in cardiac function and safe discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: